: Curaleaf says it’s trying to control costs, as big growth drivers remain elusive


U.S. multi-state cannabis producer Curaleaf Holdings Inc. CURLF, -9.76% on Wednesday reported a deeper-than-expected second-quarter loss and sales that were just short of expectations. Still, shares were up around 1% after hours. Curaleaf reported a net loss of $74.5 million, or 10 cents a share, compared with $21.8 million, or 3 cents a share, in the same quarter last year. Revenue rose around 4% to $338.6 million from $326.9 million in the prior-year quarter. The company’s adjusted net loss was 9 cents a share. Analysts polled by FactSet expected an adjusted loss of 4 cents a share, on revenue of $339.3 million. The results came amid an oversupply of weed on the U.S. legal market as federal reform efforts stall. “As the U.S. industry regains its supply-demand equilibrium and we eagerly anticipate the game-changing catalysts on the horizon, we continue to control costs and remain focused on long-term growth opportunities, particularly in Europe and our advantage in Germany specifically,” Executive Chairman Boris Jordan said in a statement.

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleThe Tell: Strategist who called 2023 U.S. stock rally says S&P 500 will go nowhere for rest of 2023, and likely in 2024 too
Next articleDisney looking to crack down on password sharing, following Netflix’s lead


Please enter your comment!
Please enter your name here